Background Drug-induced liver injury (DILI) is the most challenging and thought-provoking
liver problem for hepatologists owing to unregulated medication usage in medical practices …

Since their introduction in 1987, hydroxymethyl glutaryl coenzyme A reductase (HMG-CoA)
inhibitors, more commonly known as statins, have become some of the most widely …

Drug-induced thrombocytopenia is rarely associated with statin medications. We describe
the case of a 69-year-old woman who developed refractory thrombocytopenia following …

Introduction Atorvastatin, one of the most widely used drugs, has attracted controversy
regarding its potential adverse reactions to acute kidney injury (AKI). This study aims to …

Discussion: Statins reduce serum LDL cholesterol levels significantly. It is a safe and cost-
effective medicine used in the treatment of DLP as well as the primary and secondary …

Abstract Statins or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors are a
mainstay of cardiovascular disease therapy. In addition to their lipid-lowering capabilities …

Renal failure secondary to rhabdomyolysis due to statins is quite rare. We present a case of
a 57-year-old patient who developed acute renal failure due to rhabdomyolysis secondary to …

Drug-induced autoimmune hepatitis (AIH) is characterized by acute or chronic hepatic injury
coupled with autoantibody development, hypertransaminasemia, and idiopathic AIH …

Background: Rosuvastatin is the newest statin family drug and acts as an HMG-CoA
reductase inhibitor. Rosuvastatin can decrease the amount of cholesterol made by the liver …

Введение. Изменения липидного обмена при инфаркте миокарда (ИМ), осложненном
острым повреждением почек (ОПП), имеют важное значение для оценки эффектов …